Search results

General manager ANSTO Communications and Stakeholder Engagement was one of the presenters at the IAEA W4NSEC workshop

The Biological Small Angle X-ray Scattering beamline will be optimised for measuring small angle scattering of surfactants, nanoparticles, polymers, lipids, proteins and other biological macromolecules in solution. BioSAXS combines combine a state-of-the-art high-flux small angle scattering beamline with specialised in-line protein purification and preparation techniques for high-throughput protein analysis.

Discover the many career opportunities in the nuclear industry on a special behind the scenes tour of ANSTO.

Since 1962, the United Uranium Scholarship has helped promising young scientists in the field of nuclear energy extend their knowledge and expertise. In 2022, scholarships were awarded to several ANSTO researchers, including Phil Sutton.

Using the theory of compressed sensing technology, a team of physicists and scientists invented and developed the CORIS360® platform imaging technology. Compressed sensing imaging can generate an image with far fewer samples compared with traditional imaging techniques.

ANSTO researchers contribute to study which finds evidence of Aboriginal occupation 65,000 years ago in Northern Australia.

ANSTO plays a leading role in measuring and characterising fine particles from a range of locations around Australia and internationally.

Griffith University researchers are conducting an experiment at ANSTO that will test a revolutionary physics theory that time reversal symmetry-breaking by neutrinos might cause a time dilation at the quantum scale.

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

ANSTO has a range of capabilities and expertise to support aerospace and space research.

Defence requirements push your technology, we can help. ANSTO is home to some of Australia’s most important landmark research infrastructure – more than $1.3bn of it.  Our unique capabilities are used by thousands of Australian researchers from industry and academia every year.

Blake Orr from ARPANSA review the Netflix series Radioactive Emergency.

International interest is building in Australia’s new multi-million-dollar radioactive waste processing facility at the Sydney campus of the Australian Nuclear Science and Technology Organisation (ANSTO).

Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.

The Hungarian Ambassador to Australia and a small delegation visited ANSTO for a special ceremony to mark the installation and commissioning of two new nuclear medicine scanners from the Hungarian company Mediso Pacific.

A pioneering study led by Professor Junpei Yamanaka of Nagoya City University and an international team that included ANSTO has delivered transformative insights into the behaviour of colloidal particles under microgravity.

ANSTO continually monitors environmental gamma radiation from a station located in Engadine NSW. ANSTO uses environmental radiation data to evaluate atmospheric dispersion from its site. This radiation is almost completely natural background radiation.